• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用DNA多态性对1型多发性内分泌肿瘤进行预测性检测。

Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.

作者信息

Larsson C, Shepherd J, Nakamura Y, Blomberg C, Weber G, Werelius B, Hayward N, Teh B, Tokino T, Seizinger B

机构信息

Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden.

出版信息

J Clin Invest. 1992 Apr;89(4):1344-9. doi: 10.1172/JCI115720.

DOI:10.1172/JCI115720
PMID:1348254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC442996/
Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominantly inherited predisposition to neoplastic lesions of the parathyroids, pancreas, and the pituitary. We have previously located the predisposing genetic defect to the long arm of chromosome 11 by genetic linkage. In this study, 124 members of six MEN1 families, including 59 affected individuals, were genotyped for restriction fragment length polymorphisms with different DNA probes, and the genetic linkage between these marker systems and MEN1 was determined. 13 marker systems (17 DNA probes) were found to be linked to MEN1. These markers are located within a region on chromosome 11 spanning 14% meiotic recombinations, with the MEN1 locus in the middle. Four of the marker systems are on the centromeric side of MEN1, and four on the telomeric side, based on meiotic crossovers. The remaining five DNA probes are closely linked to MEN1, with no crossovers in our set of families. The 13 marker systems can be used for an accurate and reliable premorbid test for MEN1. In most clinical situations it is possible to identify a haplotype of this part of chromosome 11 with the mutant MEN1 allele in the middle. The calculated predictive accuracy is greater than 99.5% if three such marker systems are informative. Therefore, genetic linkage testing can be used for informed genetic counseling in MEN1 families, and to avoid unnecessary biochemical screening programs.

摘要

1型多发性内分泌腺瘤病(MEN1)是一种常染色体显性遗传疾病,易引发甲状旁腺、胰腺和垂体的肿瘤性病变。我们之前通过基因连锁分析将致病基因缺陷定位到了11号染色体长臂上。在本研究中,对6个MEN1家族的124名成员(包括59名患病个体)进行了基因分型,使用不同的DNA探针检测限制性片段长度多态性,并确定这些标记系统与MEN1之间的基因连锁关系。发现13个标记系统(17个DNA探针)与MEN1连锁。这些标记位于11号染色体上一个跨度为14%减数分裂重组的区域内,MEN1基因座位于中间。根据减数分裂交叉情况,其中4个标记系统位于MEN1的着丝粒侧,4个位于端粒侧。其余5个DNA探针与MEN1紧密连锁,在我们的家系中未出现交叉情况。这13个标记系统可用于对MEN1进行准确可靠的病前检测。在大多数临床情况下,有可能识别出11号染色体这一部分的单倍型,中间带有突变的MEN1等位基因。如果三个这样的标记系统具有信息性,计算得出的预测准确率大于99.5%。因此,基因连锁检测可用于为MEN1家族提供知情的遗传咨询,并避免不必要的生化筛查程序。

相似文献

1
Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.利用DNA多态性对1型多发性内分泌肿瘤进行预测性检测。
J Clin Invest. 1992 Apr;89(4):1344-9. doi: 10.1172/JCI115720.
2
Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
Henry Ford Hosp Med J. 1992;40(3-4):173-6.
3
Multiple endocrine neoplasia.多发性内分泌肿瘤
Cancer Surv. 1990;9(4):703-23.
4
Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.通过DNA多态性分析筛查2a型多发性内分泌腺瘤病
N Engl J Med. 1989 Oct 12;321(15):996-1001. doi: 10.1056/NEJM198910123211502.
5
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene.单倍型分析确定了多发性内分泌腺瘤1型(MEN1)基因的最小间隔区。
Cancer Res. 1997 Mar 15;57(6):1039-42.
6
Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.多发性内分泌腺瘤病1型(MEN1):对一个患病家族和散发病例的杂合性缺失研究。
Anticancer Res. 1998 Jul-Aug;18(4A):2685-9.
7
Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.通过DNA多态性分析筛查2A型多发性内分泌腺瘤病
Henry Ford Hosp Med J. 1992;40(3-4):224-6.
8
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.1型多发性内分泌腺瘤病中的甲状旁腺肿瘤与11号染色体上等位基因缺失的关联。
N Engl J Med. 1989 Jul 27;321(4):218-24. doi: 10.1056/NEJM198907273210403.
9
Closing in on the MEN2A locus.接近MEN2A基因座。
Henry Ford Hosp Med J. 1989;37(3-4):100-5.
10
Progress toward resolving the possible linkage of multiple endocrine neoplasia type 2A to haptoglobin and group-specific loci: use of restriction fragment length polymorphisms extends exclusion region.
Genet Epidemiol. 1986;3(3):195-200. doi: 10.1002/gepi.1370030306.

引用本文的文献

1
Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.中国某单一中心的 1 型多发性内分泌肿瘤患者的垂体腺瘤:单中心经验。
Pituitary. 2019 Apr;22(2):113-123. doi: 10.1007/s11102-019-00939-x.
2
Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.我们对甲状旁腺功能亢进综合征认识的演变:历史视角。
J Bone Miner Res. 2019 Jan;34(1):22-37. doi: 10.1002/jbmr.3650. Epub 2018 Dec 10.
3
Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story.1型多发性内分泌腺瘤综合征的基因检测:一个不断发展的故事。
World J Exp Med. 2015 May 20;5(2):124-9. doi: 10.5493/wjem.v5.i2.124.
4
Multiple endocrine neoplasia type 1 and adrenal Cushing's.1型多发性内分泌腺瘤病与肾上腺库欣综合征
JRSM Short Rep. 2011 Feb 10;2(2):10. doi: 10.1258/shorts.2011.010098.
5
Diffuse large B-cell lymphoma in the thyroid gland associated with primary hyperparathyroidism.甲状腺弥漫性大B细胞淋巴瘤伴原发性甲状旁腺功能亢进。
Int J Clin Oncol. 2007 Feb;12(1):48-51. doi: 10.1007/s10147-006-0620-3. Epub 2007 Feb 25.
6
Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens.石蜡包埋标本中多内分泌腺瘤病(MEN)的分子诊断
Endocr Pathol. 1995 Winter;6(4):267-278. doi: 10.1007/BF02738727.
7
The MEN1 gene and associated diseases: an update.多发性内分泌腺瘤1型基因与相关疾病:最新进展
Endocr Pathol. 2001 Fall;12(3):259-73. doi: 10.1385/ep:12:3:259.
8
Characterization of mutations in patients with multiple endocrine neoplasia type 1.1型多发性内分泌腺瘤病患者突变特征分析
Am J Hum Genet. 1998 Feb;62(2):232-44. doi: 10.1086/301729.
9
A 3-Mb contig from D11S987 to MLK3, a gene-rich region in 11q13.一条从D11S987至MLK3的3兆碱基重叠群,位于11号染色体长臂1区3带的一个基因丰富区域。
Genome Res. 1997 Aug;7(8):835-42. doi: 10.1101/gr.7.8.835.
10
Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families.1型遗传性多发性内分泌肿瘤的基因筛查:日本家族中无奠基者效应
Jpn J Cancer Res. 1996 Sep;87(9):985-94. doi: 10.1111/j.1349-7006.1996.tb02130.x.

本文引用的文献

1
ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN.一个大家族中的内分泌腺瘤病和消化性溃疡。人类遗传性多发性肿瘤和镶嵌性多效性。
Am J Med. 1963 Aug;35:205-12. doi: 10.1016/0002-9343(63)90212-2.
2
Characterization and localization of the products of the human homologs of the v-ets oncogene.
Oncogene. 1988 Feb;2(2):99-103.
3
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.多发性内分泌腺瘤1型基因定位于11号染色体,在胰岛素瘤中缺失。
Nature. 1988 Mar 3;332(6159):85-7. doi: 10.1038/332085a0.
4
Familial multiple endocrine neoplasia type I: a new look at pathophysiology.家族性I型多发性内分泌肿瘤:病理生理学新视角
Endocr Rev. 1987 Nov;8(4):391-405. doi: 10.1210/edrv-8-4-391.
5
Latent familial multiple endocrine neoplasia in Tasmania.塔斯马尼亚的潜伏性家族性多发性内分泌肿瘤
Med J Aust. 1985 Apr 1;142(7):395-7. doi: 10.5694/j.1326-5377.1985.tb133152.x.
6
Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms.
Cytogenet Cell Genet. 1989;51(1-4):622-947. doi: 10.1159/000132810.
7
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.1型多发性内分泌腺瘤病中的甲状旁腺肿瘤与11号染色体上等位基因缺失的关联。
N Engl J Med. 1989 Jul 27;321(4):218-24. doi: 10.1056/NEJM198907273210403.
8
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.1型家族性多发性内分泌腺瘤病中甲状旁腺肿瘤的克隆性
N Engl J Med. 1989 Jul 27;321(4):213-8. doi: 10.1056/NEJM198907273210402.
9
Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.1型多发性内分泌肿瘤基因缺陷在11号染色体一小区域内的定位
Am J Hum Genet. 1989 May;44(5):751-5.
10
Clonal loss of INT-2 alleles in sporadic and familial pancreatic endocrine tumours.散发性和家族性胰腺内分泌肿瘤中INT-2等位基因的克隆性缺失。
Br J Cancer. 1990 Aug;62(2):253-4. doi: 10.1038/bjc.1990.270.